116 related articles for article (PubMed ID: 15210480)
1. Steroid-sparing effect of extracorporeal photopheresis in the treatment of graft-vs-host disease.
Coyle TS; Nam TK; Camouse MM; Stevens SR; Baron ED
Arch Dermatol; 2004 Jun; 140(6):763-4. PubMed ID: 15210480
[No Abstract] [Full Text] [Related]
2. [Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases].
D'incan M; Kanold J; Halle P; De Lumley L; Souteyrand P; Deméocq F
Ann Dermatol Venereol; 2000 Feb; 127(2):166-70. PubMed ID: 10739974
[TBL] [Abstract][Full Text] [Related]
3. The effect of budesonide mouthwash on oral chronic graft versus host disease.
Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
[TBL] [Abstract][Full Text] [Related]
4. Oral graft-versus-host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus.
Schlaak M; Treudler R; Colsman A; Al-Ali H; Simon JC
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):112-3. PubMed ID: 18181987
[No Abstract] [Full Text] [Related]
5. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
Greinix HT; Worel N; Knobler R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
[No Abstract] [Full Text] [Related]
6. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
[TBL] [Abstract][Full Text] [Related]
7. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis in graft-versus-host disease.
Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
[TBL] [Abstract][Full Text] [Related]
10. Optimal initial dose of oral cyclosporine in relation to its toxicities for graft-versus-host disease prophylaxis following reduced-intensity stem cell transplantation in Japanese patients.
Kishi Y; Murashige N; Kami M; Miyakoshi S; Shibagaki Y; Hamaki T; Takaue Y; Taniguchi S;
Bone Marrow Transplant; 2005 Jun; 35(11):1079-82. PubMed ID: 15806118
[TBL] [Abstract][Full Text] [Related]
11. Chronic graft versus host disease of oral mucosa: review of available therapies.
Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photochemotherapy for treatment of fasciitis in chronic graft-versus-host disease.
Sbano P; Rubegni P; De Aloe GB; Guidi S; Fimiani M
Bone Marrow Transplant; 2004 Apr; 33(8):869-70. PubMed ID: 14743190
[No Abstract] [Full Text] [Related]
13. Feasibility of early tapering of cyclosporine following reduced-intensity stem cell transplantation for advanced hematologic or solid malignancies.
Hori A; Kami M; Ohnishi M; Murashige N; Kojima R; Takaue Y
Haematologica; 2005 Jul; 90(7):1001-3. PubMed ID: 15996949
[TBL] [Abstract][Full Text] [Related]
14. Rapid tapering of cyclosporin to maximise the graft-versus-leukaemia effect.
Shaw PJ; Afify Z
Bone Marrow Transplant; 1999 Mar; 23(6):632-3. PubMed ID: 10217198
[No Abstract] [Full Text] [Related]
15. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
Rao SN; Rao RD
Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis in children with graft-versus-host disease.
Chan KW
J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
Komanduri KV; Couriel D; Champlin RE
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
[TBL] [Abstract][Full Text] [Related]
18. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis in the treatment of graft-vs-host disease.
Foss FM
J Cutan Med Surg; 2003; 7(4 Suppl):13-7. PubMed ID: 12958702
[No Abstract] [Full Text] [Related]
20. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
